FMS
Fresenius Medical Care AGPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 24 Cynthia D. Biggs El v. Fresenius Medical Care North…
- Mar 30 ▼ The District Court for the District of Columbia dismissed Fresenius…
- Apr 7 ▲ The Ninth Circuit Court of Appeals ruled that key provisions of Cali…
- Jun 29 Jerry Jerome Harris v. Bio-Medical Application of Texas…
- Aug 31 Fresenius Kabi, LLC received a $25.4 million contract modification f…
- Aug 31 to Sep 1 2 court rulings: Fresenius USA Manufacturing, Inc. v. Much; Covington v. Fresenius Medical Care
- Oct 15 ▼ Short interest jumps 39.7% to 3.96M
- Oct 30 United States of America et al v. Fresenius Vascular Care…
- Nov 3 ▼ Fresenius Medical Care reported Q3 2026 revenue of EUR 4.937B, up 1%…
- Nov 9 ▼ Barclays downgrades
Signal stack
Where each data set points today.
- InstitutionsBULLISH
Q3 2026: 19 added (0 new), 7 trimmed or exited.
- AnalystsMIXED
6 of 29 rate it Buy or better.
- Short sellersCOVERING
Short interest −24.0% to 3.01M shares. 2.2 days to cover, ≈0.5% of shares.
- TrendRANGE
2% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | $10.7M |
| JPMORGAN CHASE & CO | ADD | $7.7M |
| UBS Group AG | ADD | $7.1M |
| HRT FINANCIAL LP | ADD | $6.9M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $2.5M |
| SEI INVESTMENTS CO | ADD | $2.3M |
| AMERICAN CENTURY COMPANIES INC | ADD | $1.4M |
| Orion Porfolio Solutions, LLC | ADD | $984.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
29 analysts| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Barclays DOWNGRADE | Underweight |
| Oct 12, 2026 | Truist Securities MAINTAIN | Hold |
| Aug 6, 2026 | Bernstein MAINTAIN | Market Perform |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
16 filings · 2 bullish · 5 bearish · 1 mixed · 8 neutral- BEARISH SC 13D/ANov 13, 2026
Fresenius SE & Co. KGaA, the controlling shareholder of Fresenius Medical Care AG (FMS), sold…
The 5% secondary offering by the controlling shareholder signals potential further monetization of the FMS stake over time. The 90-day lock-up provides near-term certainty on no additional overhang…
- NEUTRAL 6-KNov 9, 2026
Fresenius Medical Care placed a €500 million bond maturing in February 2032 with a 4.250% coupon…
The bond issuance is a routine refinancing transaction. Monitor the company's upcoming quarterly results for any changes in leverage or interest coverage ratios.
- BEARISH 6-KNov 3, 2026
Fresenius Medical Care reported Q3 2026 revenue of EUR 4.937B, up 1% as reported (down 1% constant…
The Q3 results show accelerating margin pressure from inflation, restructuring costs, and declining treatment volumes in the U.S. The new CEO's strategy update and the pace of FME25+ savings…
- BEARISH 6-KNov 3, 2026
Fresenius Medical Care reported Q3 2026 revenue of EUR 4,937M (+1% YoY, -1% constant currency) and…
The narrowed FY 2026 operating income outlook to flat/negative mid-single-digit growth signals continued headwinds from TDAPA regulations and inflation. Monitor Q4 results for the full-year exit…
All FMS filing & press-release reports (16)
- SC 13D/A reportNov 13, 2026
- 6-K reportNov 9, 2026
- 6-K reportNov 3, 2026
- 6-K reportNov 3, 2026
- COURT-RULING reportOct 30, 2026
- 6-K reportOct 7, 2026
- 6-K reportSep 25, 2026
- COURT-RULING reportSep 1, 2026
- COURT-RULING reportAug 31, 2026
- GOVT-CONTRACT reportAug 31, 2026
- 6-K reportAug 27, 2026
- 6-K reportAug 4, 2026
- COURT-RULING reportJun 29, 2026
- COURT-RULING reportFeb 24, 2026
- COURT-RULING reportApr 7, 2026
- COURT-RULING reportMar 30, 2026